US2025279158A1PendingUtilityA1

Computer-assisted method and system for evaluating and modifying immunogenicity of protein sequences using a protein large language model

Assignee: Pan LurongPriority: Feb 29, 2024Filed: Feb 29, 2024Published: Sep 4, 2025
Est. expiryFeb 29, 2044(~17.6 yrs left)· nominal 20-yr term from priority
Inventors:Lurong Pan
G16B 15/30G16B 40/20G16B 50/30G16B 40/30
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The embodiment discloses a computer-assisted method for evaluating and modifying immunogenicity, as well as related computer systems and storage media. The method includes using unsupervised learning of a protein large language model on all human sequences and a supervised deep learning neural networks to establish a predictive scoring model for the humanness score of peptide chains based on the data from the model training dataset to achieve classification between human and non-human species. This involves cutting protein sequences into all possible peptide chains of a preset length using a dynamic window method and importing these chains into the predictive scoring, thereby evaluating their immunogenicity in terms of humanness score. Peptide chains with scores above a certain threshold undergo all possible single-point virtual mutations to generate a set of modified peptide chains which are then reassessed using the model, selecting those with scores above the threshold of humanness for further consideration.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A computer-assisted method for evaluating immunogenicity of protein sequences using a protein large language model, characterized by:
 establishing a predictive scoring model for the humanness score of protein sequences using a deep learning neural network, including a protein large language model, based on data from a model training dataset comprising various human and non-human species protein sequence information.   obtaining protein sequences and processing them into peptide chains of a preset length using a dynamic window method.   importing these peptide chains into the protein large language model for scoring each chain's humanness score, thereby evaluating their immunogenicity.   
     
     
         2 . The method according to  claim 1 , further characterized by:
 storing peptide chains whose humanness score, as determined by the protein large language model, are smaller than or equal to a first preset threshold; and/or   marking cutting sites on the protein sequence where the humanness scores are smaller than or equal to a first preset threshold.   
     
     
         3 . The method according to  claim 1 , wherein obtaining protein sequences includes translating protein sequences into FASTA format files and importing these files into the protein large language model through tokenization. 
     
     
         4 . The method according to  claim 1 , where the data of the model training dataset is processed through the protein large language model. 
     
     
         5 . The method according to  claim 1 , wherein the protein large language model is part of a unsupervised deep learning model, which is integrated with a combination of supervised learning models including CNN, RNN, GNN, VAE and Transformer models, all tailored for analyzing protein sequences. 
     
     
         6 . A computer-assisted method for modifying immunogenicity of protein sequences using a protein large language model, characterized by:
 implementing the method for evaluating immunogenicity as described in claims  1  to  5 ;   identifying, via the protein large language model that includes CNN, RNN, GNN, VAE and Transformer models, peptide chains whose humanness scores are smaller than or equal to a second preset threshold;   performing all possible single-point virtual mutations on these identified peptide chains to generate a set of modified peptide chains;   scoring the humanness score of each modified peptide chain using the protein large language model that includes CNN, RNN, GNN, VAE and Transformer models; and   selecting modified peptide chains whose humanness scores are more than the second preset threshold.   
     
     
         7 . A computer system for evaluating and/or modifying immunogenicity of protein sequences, characterized by including a processor and a memory connected to the processor, wherein the memory stores a program executable by the processor to implement the method for evaluating and/or modifying immunogenicity using a protein large language model, as described in any one of  claims 1 to 6 , wherein the protein large language model followed by a combination of CNN, RNN, GNN, VAE and Transformer models for comprehensive protein sequence analysis. 
     
     
         8 . A computer-readable storage medium, characterized by storing a computer program, which, when executed by a processor, implements the method for evaluating and/or modifying immunogenicity of protein sequences using a protein large language model, according to any one of  claims 1 to 6 , wherein the protein large language model includes CNN, RNN, GNN, VAE and Transformer models as part of its deep learning architecture.

Join the waitlist — get patent alerts

Track US2025279158A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.